Alert: New Earnings Report (5/1/24)-Neurocrine Biosciences Inc (NASDAQ: NBIX).
Neurocrine Biosciences Inc (NASDAQ: NBIX) has reported earnings for its first fiscal quarter (ending March 31) of $0.43 versus a loss $-0.79 for the same period a year ago. This result fell short of the […]